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Autophagy mutations are important in human autoimmune diseases, and surface receptors that can modulate autophagy function provide avenues for therapeutic manipulation. Chaudhary et al. report that surface receptor CD244 is an inhibitor of autophagy and that its activity is modulated upon ligand binding.
SUMMARY
Mutations in genes encoding autophagy proteins have been associated with human autoimmune diseases, suggesting that diversity in autophagy responses could be associated with disease susceptibility or severity. A cellular genome-wide association study (GWAS) screen was performed to explore normal human diversity in responses to rapamycin, a microbial product that induces autophagy. Cells from several human populations demonstrated variability in expression of a cell surface receptor, CD244 (SlamF4, 2B4), that correlated with changes in rapamycin-induced autophagy. High expression of CD244 and receptor activation with its endogenous ligand CD48 inhibited starvation-and rapamycin-induced autophagy by promoting association of CD244 with the autophagy complex proteins Vps34 and Beclin-1. The association of CD244 with this complex reduced Vps34 lipid kinase activity. Lack of CD244 is associated with auto-antibody production in mice, and lower expression of human CD244 has previously been implicated in severity of human rheumatoid arthritis and systemic lupus erythematosus, indicating that increased autophagy as a result of low levels of CD244 may alter disease outcomes.
INTRODUCTION
An understanding of normal human genetic variation can inform us about disease risk and response to treatment. Cellular genome-wide association study (GWAS) approaches that identify effects of human genetic variation on specific molecular pathways can provide important mechanistic insights on the pathophysiology of complex diseases [1, 2] . Therefore, we performed a cellular GWAS screen to define human variation in the Hapmap B cell-derived immunoblast response to rapamycin (sirolimus), a clinical immunosuppressant. Rapamycin stimulates autophagy, a cellular homeostasis pathway important in thymic selection of T cells, survival of B cells, immune tolerance, and antigen presentation, by the inhibition of mammalian target of rapamycin (mTOR) complexes [3] . Autophagy is critical to antigen presentation and the development of acquired and innate immune responses, indicating that understanding common differences in human autophagy could inform about vaccine efficacy and autoimmunity. Dysregulation of autophagy has been implicated in various autoimmune disorders [4, 5] . Here we have identified common human variation in CD244 expression as a contributor to human cellular variation in autophagy responses to rapamycin and serum starvation.
RESULTS

A Flow Cytometry-Based Screen Was Developed Using Hapmap Lymphoblastoid Cells to Identify Human Genetic Variation in the Response to Rapamycin
We measured rapamycin-induced organelle acidification in 479 genotyped Hapmap lymphoblastoid cells (LCLs) from various populations to identify common human genetic variation that influences this phenotype. Using pH-sensitive, cell-permeable dyes that report on organelle acidification in live cells [6] , we first noted that exposure of cells to controlled doses of rapamycin induced a new population of cells with increased fluorescence that could be defined by flow cytometry. This new population (M1), when cell sorted and analyzed by western blotting, demonstrated an increased degradation of autophagy marker LC3B II [7] that accumulated upon bafilomycin A treatment, indicating that this population was undergoing more autophagy (Figures S1A and S1B). The variation in number of cells induced in this population in response to rapamycin therefore can be used as a quantitative trait to measure human cellular variation in the induction of autophagy. Consistently, the induction of this cell population in response to rapamycin also was responsive to the inhibition of phosphatidylinositol 3 0 kinase by pharmacological agents [8] and sensitive to silencing of known autophagy genes, further confirming it represented cells undergoing an autophagic response ( Figures S1C and S1D) . Therefore, the cells that show an induction in acidic organelles in response to rapamycin (M1) are cells with induced autophagy, since biochemical characterizations performed in tandem have determined that these cells have a significant increase in markers of autophagy. We measured variation in this quantitative trait in 479 LCLs treated with 50 mM rapamycin, a dose that demonstrated a linear organelle acidification response and low cell death for a representative set of LCLs ( Figure S1E ).
Hapmap Cells Demonstrate Significant Human Variation in the Rapamycin-Induced Response that Is Heritable Using fixed gating parameters, we then screened LCLs for the number of cells induced in M1 upon rapamycin treatment of each LCL (Figures S1F and S1G ). Control buffer-treated LCLs demonstrated a broad range of basally stained acidic organelles (0.28%-40.99%, n = 479; Figure S1H ). Rapamycin-treated LCLs demonstrated a robust range in the number of cells induced in M1 (6.82%-70.69%, n = 479, with the exception of one outlier LCL that showed a dramatic induction in 82.36% cells; Figure 1A ). LCLs from various populations showed significant differences in the intra-population mean for this rapamycin response. LCLs from Yoruba in Ibadan, Nigeria (YRI) showed a 6% lower mean induction compared to cells from Utah residents with northern and western European ancestry (CEU, p < 0.0001) or cells of East Asian ancestry (ASN, p = 0.0003) ( Figure 1A) . A similar lower induction was noted in smaller sets of cells from Luhya in Webuye, Kenya (LWK); Toscani in Italia (TSI); and African ancestry in southwest USA (ASW) compared to CEU and ASN LCLs ( Figure S1I ), concurring that cells of African ancestry could have a lower induction of autophagy, although these sets are too small to make significant population interpretations. A subset of the YRI and CEU LCLs is from parent-offspring trios, allowing us to measure the contribution of genetic factors to the rapamycin response. Mid-parent offspring linear regression of the phenotypic data for 85 CEU and YRI families indicated that an estimated 43.09% ± 8.495% of the observed phenotypic variance was attributable to genetic factors (R 2 = 0.2366, 95% confidence interval [CI] 26.16%-60.01%, p < 0.0001 for the slope to be significantly non-zero; Figure 1B ). These data indicate that the population differences in LCL responses to rapamycin are highly likely a result of genetic differences that can be identified.
Genotype-Phenotype Association Analysis Identified cis-eQTL SNPs in CD244 as Associated with Differences in the Response to Rapamycin
We carried out family-based association analysis [9] that uses linear regression of phenotype on genotype and, subsequently, adaptive permutation to control for family structure. Familybased association analysis with parental phenotypes (QFAMparents) was performed on the combined CEU-YRI dataset and on CEU and YRI populations, respectively. Given our small sample size of 479 LCLs, no SNPs reached genome-wide significance after correcting for multiple hypothesis testing; however, p values were not used to strictly define statistically significant associations but as a tool for narrowing down candidate SNPs for subsequent experimental analyses. Quantile-quantile plots for observed p values demonstrated the lack of test statistic inflation ( Figure S2A ). A block of three proximal SNPs in intron 1 of the CD244 gene on chromosome 1, rs512525, rs489651, and rs4656938 had significant p values in QFAM-family of combined CEU-YRI and also upon individual CEU analysis ( Figure S2B ). While it did not have the lowest p value in SNPs that emerged from the screen, rs512525 is a cis expression quantitative trait locus (cis-eQTL) [10] for CD244 (2B4 or SlamF4), a member of the signaling lymphocyte activation molecule (SLAM) family of proteins, which have important co-stimulatory functions in natural killer cell lymphocyte populations [11] . A role for CD244 in autophagy was not known. CD244 previously has been implicated in linkage and association studies with susceptibility to systemic lupus erythematosus (SLE) and rheumatoid arthritis in certain human populations [12] [13] [14] [15] . A role for mouse CD244 in the control of inflammation and maintenance of homeostasis in the intestine also recently has been identified, and CD244-null mice develop auto-antibodies [16] . A SNP in linkage disequilibrium (LD) [17] with rs512525, rs6682654 ( Figure S2C ), is associated with higher odds of neuropsychiatric lupus (odds ratio [OR] 3.47, 95% CI 2.12-5.70, p = 1.6 3 10À7) [18] , suggesting an effect on disease severity ( Figure S2B ). While SNP rs512525 shows considerable variation in allele frequencies among various populations, with San hunter-gatherers from Africa (SA001469U) having the lowest derived allele (A) frequency at 0.080 and farming Pimas from Mexico (SA001511I) having the highest at 0.780 ( Figure S2E ), there was no evidence for unusual population differentiation at this locus (F ST = 0.11) [19] . LCLs homozygous for the derived allele (AA) at rs512525 showed a mean 7.83% higher induction of autophagy in response to rapamycin compared to ancestral allele (CC) homozygous cells ( Figure 1C ; p < 0.001).
Enhancer Region SNPs Are Regulatory for CD244 Expression Since rs512525 is a predicted cis-eQTL for CD244 ( Figure S2B ), we examined the correlation between CD244 mRNA expression [10] and rapamycin response in 263 matched LCLs, including 55 CEU, 87 YRI, 20 LWK, and 101 ASN LCLs for which both expression and screen data were available, and we noted significant inverse correlation ( Figure 1D ). Since CD244 expression correlated with the induction of rapamycin-mediated autophagy, we therefore investigated the putative causative genetic variants attributed to CD244 expression levels. We performed eQTL analyses in CD244 and its flanking regions. Integrated with sequencing data from the 1000 Genomes Project [20] , eQTL analysis was performed in 292 unrelated sequenced individuals and in 331 unrelated individuals with imputation, spanning five populations in East Asia, South Asia, and Africa. Since these eQTL results were consistent with one another (Figure S2F) , we have reported the eQTL results based on the sequenced samples alone.
In a Japanese in Tokyo, Japan (JPT) population, we identified 11 SNPs, including SNPs identified in the autophagy screen (rs489651 and rs4656938; Figure S2B ) as significantly associated with CD244 expression (p % 0.0005 after Bonferroni correction). Among them, rs541834, which is in complete LD (r 2 = 1 in JPT) with rs489651 and rs4656938, was identified in an enhancer region (chr1:160814488-160814687, hg19) according to the database of Ensembl Regulation 77 in multiple cell lines ( Figure 1E ). Additionally, rs512525 was in complete LD (r 2 = 1 in JPT) with another SNP, rs537957, in this enhancer region, and both of them were associated with CD244 expression in JPT (p = 0.0009). In the Gujarati Indian from Houston (GIH) and LWK populations, rs537957 was also in LD with rs512525 (r 2 = 0.974 in GIH and 0.674 in LWK), and likely attributed to CD244 expression (p = 0.0098 in GIH and p = 0.0085 in LWK). We further verified this eQTL analysis by tapping into the Geuvadis RNA sequence database [21] ), such as rs489651 (p = 2 3 10 À19 ), rs4656938 (p = 9.18 3 10 À21 ), and rs512525 (p = 5.23 3 10 À20 ), were highly linked with rs541834 or rs537957 (r 2 R 0.8) ( Figure 1F ). Therefore, the enhancer region (chr1:160814488-160814687, hg19) of CD244 may be highly regulatory for CD244 expression.
Levels of CD244 Expression Correlate with the Inhibition of Cellular Autophagy
Since rs512525 is a predicted cis-eQTL for CD244 in CEU, YRI, and ASN LCLs (Figure 2A ) [10] , we verified mRNA and protein expression of CD244 in a representative set of LCLs using real-time qPCR and western blot ( Figure S3A ). Indeed, ancestral allele homozygous cells showed higher mean levels of CD244 transcript and protein, with greater between-individual variation. LCLs homozygous for the derived allele showed lower levels of both CD244 transcript and protein. The mRNA and protein levels in a representative set of LCLs showed good correlation (R 2 = 0.79, p = 0.0033; Figure S3B ). If CD244 levels alter rapamycin-induced autophagy, a reduction of CD244 should mimic the derived allele phenotype and demonstrate increased autophagy. We therefore silenced CD244 using small interfering RNA (siRNA) in human monocyte-derived THP1 cells, and this triggered higher induction of cells with acidic organelles compared to control siRNAtreated cells (Figures 2B and S3C) . Correlatively, plasmidbased overexpression of CD244 in THP1 cells suppressed the induction of the rapamycin effect ( Figure 2B ). The overexpression of CD244 in HEK293T cells showed suppression of key autophagy markers, including degradation of autophagosome substrate p62 (sequestosome, SQSTM1 [7] ), the dephosphorylation of mTOR ( Figure 2C ), and the lipidation of LC3B upon rapamycin treatment ( Figure S3D ). In addition, co-expression of CD244 in HEK293T cells inhibited the rapamycin-mediated cleavage of GFP-LC3 ( Figure 2D ). GFP-LC3-expressing cells also showed fewer LC3B puncta per cell upon immunofluorescence analysis ( Figures 2E and S3E ). Together these data confirmed that CD244 expression inhibits cellular autophagy in response to rapamycin.
We next examined the effects of CD244 expression on the induction of autophagy in primary macrophages from mice. Resting bone marrow-derived macrophages (BMDMs) from CD244-null mice (CD244 À/À ) [22] showed more cells with basal staining of acidic organelles, compared to macrophages from the background strain C57BL/6 wild-type mice (CD244 +/+ ) (Figure S3F) , and higher induction in response to rapamycin that was inhibited upon silencing Atg10 ( Figure S3G ). In addition, rapamycin-treated BMDMs from CD244 À/À mice showed a significantly higher number of LC3B puncta per cell compared to CD244 +/+ BMDMs ( Figures 2F and 2G ). At longer time points, CD244 À/À BMDMs showed notable degradation of LC3B that was rescued upon chloroquine treatment ( Figure S3H ). CD244 À/À BMDMs also showed more degradation of p62 in response to rapamycin treatment than CD244 +/+ BMDMs, an effect that could be rescued upon lentiviral-based overexpression of CD244 ( Figures 2H and S3F ). The p62 mRNA and protein levels were consistent in CD244 +/+ and CD244 À/À BMDMs (Figures S3I and 2H ), confirming protein degradation of this autophagosome substrate. Together these data confirmed that CD244 expression levels can influence cellular autophagy in response to rapamycin in mice and humans and that these effects extend to non-transformed primary cells.
CD244 Inhibits Starvation-Induced Autophagy through Binding of Its Ligand CD48
We next asked whether a role for CD244 in autophagy was limited to cellular pathways triggered by rapamycin. Serum starvation of BMDMs induced higher autophagy in CD244
À/À BMDMs compared to CD244 +/+ BMDMs, as determined by the induction of acidic organelles ( Figure S3J ; p = 0.03) and LC3B puncta per cell ( Figures S4A and S4B) . Interestingly, serum starvation also induced CD244 expression, as serum-starved THP1 cells showed a robust 10-fold induction of CD244 mRNA (Figure 3A ) compared to cells in 10% serum. Together these data indicate that CD244 levels control cellular autophagy and its expression is regulated by autophagy stimuli. CD244 is unique in the SLAM family as it has a heterophilic ligand, CD48, while other family members function as self ligands [23, 24] . In addition, the level of CD244 ligation by ligand can determine its function [25] . Immunofluorescence and flow cytometry measurements confirmed a membrane localization of CD244 in LCLs and THP1 cells, indicating that the extracellular ligand could have an effect on CD244 signaling (Figures S4C and  S4D) . Therefore, we investigated the effect of CD48 on autophagy. Pre-treatment of THP1 cells with CD48 or the monoclonal antibody C1.7, which binds the same site as CD48 [26] , inhibited the rapamycin-mediated induction of acidic organelles (Figure 3B) . Both CD48 and C1.7 also inhibited the rapamycin-mediated lipidation of LC3B and the degradation of p62 in THP1 cells ( Figure 3C ). The ligand by itself had no effect on autophagy ( Figures 3C, S4E, and S4F ). The ligand effect was reproducible in mouse macrophages: the mouse anti-CD244 antibody and recombinant CD48 inhibited rapamycin-and starvation-induced autophagy in BMDMs from wild-type mice and showed no effect on CD244 À/À BMDMs ( Figures 3D-3F , S4A, and S4B). Finally, consistent with the inhibition of autophagy by CD48, ligand binding to both control and serum-starved cells robustly inhibited the lipid kinase activity of Beclin-1-associated Vps34 in THP1 cells, as determined by the generation of significantly less g 33 -labeled phosphatidylinositol 3-phosphate (PI(3)P) in a Vps34 in vitro kinase assay ( Figure 4A ). Since ligand-bound CD244 inhibited autophagy, we investigated if expression differences in human CD48 could contribute to the human variation in response observed in this study. The mRNA expression data from Hapmap LCLs [10] indicated no significant differences in expression of CD48 among ancestral and derived allele homozygous LCLs characterized with respect to CD244 cis-eQTL SNP rs512525 ( Figure S4G ). Together these data indicate that ligand-mediated activation of CD244 inhibits the induction of autophagy and the human cellular autophagy variation is a result of expression of the receptor CD244 and not its endogenous ligand CD48. 
The CD244-Associated Adaptor Protein Eat2 Is an Important Component of CD244 Inhibition of Autophagy
The cytosolic portion of CD244 is known to associate with various adaptor proteins upon ligand binding, including adaptor protein SAP (SH2D1A) [25, 27] , the tyrosine phosphatase PTP11, and adaptor protein Eat2 (SH2D1B) [28, 29] . Therefore, we investigated effects of these signaling components on CD244-mediated inhibition of autophagy. While gene silencing of SAP in LCLs and THP1 cells had no effect on the rapamycin-induced acidic organelles ( Figure S4H ), silencing of PTP11 further induced it ( Figure S4I ). In contrast, silencing of adaptor Eat2 robustly inhibited the induction of acidic organelles in response to rapamycin ( Figure 4B ). Silencing of Eat2 also had a profound effect on the dephosphorylation of mTOR in response to CD244 alone ( Figure 4D ). Together these data indicate that the effects of CD244 on suppression of rapamycin function are dependent on recruitment of the intracellular adaptor Eat2.
CD244 Associates with Autophagy Complex Proteins Beclin-1/Vps34
The related receptor and family member SLAMF1 previously has been shown to recruit the Beclin-1/Vps34/UVRAG complex [31] . While a role for SLAMF1 in autophagy remains to be determined, the Beclin-1/Vps34 complex is critical for the initiation and continuance of cellular autophagy [32, 33] . SLAMF1 and CD244 show low similarity in primary sequence (24% identity E value 1 3 10
À18
); nonetheless, they share common adaptor proteins for intracellular signaling [34] , and, therefore, we investigated if CD244 could associate with the Beclin-1/Vps34 complex. Indeed, Vps34 co-immunoprecipitated with CD244 in a CD244 pull-down from HEK293T cells overexpressing CD244 and Vps34 (Figure 4E ). Endogenous CD244 also was detectable with Beclin-1 and Vps34 in a Beclin-1 pull-down from CD244 +/+ BMDMs (Figure 4F) . Furthermore, the overexpression of CD244 in HEK293T cells correlated with decreased lipid kinase activity of Vps34 associated with Beclin-1 in these cells, as determined by the generation of significantly less g 33 -labeled PI(3)P in a Vps34 in vitro kinase assay ( Figure 4G ). Together these data indicate that CD244 can associate with the Beclin-1/Vps34 autophagy complex and reduce the lipid kinase activity of this complex.
Ligand-Mediated Activation of CD244 Promotes the Association of CD244 with Beclin-1/Vps34 To explore the mechanism by which ligand-activated CD244 inhibits autophagy, we further examined the interactions of CD244 with the autophagy complex in the presence of ligand. Ligand binding induced the association of CD244 with Beclin-1 in Beclin-1 pull-downs from BMDMs ( Figure 4F ). Additionally, in human THP1 cells, ligand binding induced the association of Vps34 in a CD244 pull-down ( Figure 4H ). Interestingly, upon serum deprivation, Vps34 association with CD244 was considerably reduced. In parallel, ligand binding decreased the association of Eat2 with CD244, and this association was induced upon serum starvation of cells ( Figure 4H ). In mouse, Eat2 genes are duplicated and the coding regions of the mouse Eat2A and Eat2B genes are 84% identical at the protein level [35] . In transient transfections, Eat2B and Vps34, but not Eat2A, co-immunoprecipitated with CD244 ( Figure S4J ). Additionally, co-expression of Eat2B, but not Eat2A, reduced the association of Vps34 with CD244. Together these data indicate that CD244 associates with Vps34 autophagy complex or Eat2, depending on CD244's activation state.
Since Eat2 overexpression induced autophagy, we investigated if expression differences in Eat2 in Hapmap LCLs could contribute to the human variation in response observed in this study. The mRNA expression data from Hapmap LCLs [10] indicated no significant differences in expression of Eat2 among ancestral and derived allele homozygous LCLs characterized with respect to CD244 cis-eQTL SNP rs512525 ( Figure S4K ) or among CEU, YRI, and ASN LCLs ( Figure S4L ). These data indicate that, while overexpression of adaptor protein Eat2 can rescue CD244-mediated inhibition of autophagy, the LCL variation in autophagy is not a consequence of expression variation of Eat2.
DISCUSSION
We demonstrate here that human variation in expression of a cell surface co-stimulatory receptor CD244, likely as a result of enhancer region SNPs, correlates with variation in cellular autophagy. In a screen of Hapmap LCLs examining variation in organelle acidification responses to rapamycin, where a subset of the genes identified may modulate autophagy, CD244 expression variation emerged as a contributor to >10% variation in this overall response ( Figure 1C) . While the significance of this variation to maintenance of cellular homeostasis and relevance to disease remain unexplored, given the hematopoietic expression of CD244, it is plausible that this expression variation could have an effect on antigen presentation. In addition, while the relationship between individual-level CD244 variation and autophagy induction are defined in overexpression and gene silencing experiments in human cell lines and in cells from CD244-null mice, how different evolutionary forces interact to shape CD244 variation at the level of populations remains poorly understood. It is tempting to speculate that a fitness advantage could be conferred as a result of higher autophagy in human immune cells in environs with high pathogen loads or specific starvation pressures.
Our results further reveal interesting insights into the mechanism of CD244 suppression of autophagy. Upon activation, CD244 interacts with the Beclin-1/Vps34 autophagy complex ( Figures 4E, 4F , and 4H) that is crucial for autophagosome formation. The ability of CD244 to associate with Beclin-1/Vps34 correlates with lower lipid kinase activity of this complex, leading to less PI(3)P generation ( Figure 4G ), a phospholipid important for the initiation of autophagy. In addition, CD244 can associate with adaptor protein Eat2, and it is partitioned between Eat2 and the Beclin-1/Vps34 complex, depending on the activation state of CD244. In serum-starved cells, upon induction of autophagy, the association of Vps34 with CD244 is decreased, whereas the association of Eat2 with CD244 is enhanced ( Figure 4H ). It is plausible that the CD244/Eat2 and CD244/Beclin-1/Vps34 complexes have distinct downstream consequences; while the former influences mTOR activation and lysosomal acidity, the latter (through modulation of Vps34 activity) has a distinct effect on the initiation of autophagy in the cell.
The exact molecular mechanism by which CD244 association inhibits Vps34 activity remains to be detailed. The epidermal growth factor receptor-mediated suppression of autophagy occurs by tyrosine phosphorylation of Beclin-1 [36] . Similarly, AMPK can modulate this complex by mediating serine/threonine phosphorylation of Beclin-1/Vps34 [37] . While CD244 itself does not possess intrinsic kinase activity, it may direct a cytosolicassociated kinase. The role of Eat2 in controlling rapamycinmediated mTOR function is intriguing and requires further investigation to dissect its contributions to mTORC1/2 pathways ( Figures 4B and 4C) . It is possible that this adaptor protein plays a role in controlling lysosomal function of not just CD244 ( Figures  4B-4D ) but other receptors as well, since Eat2 can bind multiple Slam receptors [30] . Nonetheless, overexpression of Eat2 can rescue CD244-mediated inhibition of rapamycin responses (Figure 4D) . Together these findings demonstrate a hitherto unknown link between CD244 and the autophagy machinery, and they also provide contextual relevance of normal human variation of this receptor in humans and its effect on autophagy. A model of CD244-mediated inhibition of autophagy in host cells is depicted ( Figure S4M ).
Surface receptor-based modulation of autophagy has broad implications in not only sensing environmental cues that determine cellular responses but also in therapies. In immune cells, autophagy modulation by extracellular signals has wide ramifications, since autophagy can influence the antigenic profile and the ability of antigen donor cells to release immunogenic signals [38, 39] as well as the survival, differentiation, and function of antigen-presenting cells and T lymphocytes [40] [41] [42] . Consistent with more CD244 expression resulting in less autophagy, the endogenous ligand of CD244, CD48, inhibits autophagy. Therefore, it is plausible that the low expression of CD244 in some autoimmune diseases may play a pathogenic role in increasing the risk of stimulation of autophagy-mediated antigen presentation. Lower CD244 expression levels have been noted previously in some SLE patients compared to healthy controls [43] , and CD244 knockout mice spontaneously develop dramatic auto-antibodies and increased cytotoxic intraepithelial CD8 (+) T cells compared to wild-type mice [16, 22] . It is interesting to speculate that increasing autophagy and subsequent antigen presentation as a result of lack of CD244 promotes these increased autoimmune responses. The use of CD48 or antibody ligands for CD244 that will inhibit autophagy could thus foreseeably be useful in diseases such as SLE, by suppression of auto-antibody production. Stimulation of autophagy by blocking the CD48 interaction with CD244 could benefit patients with diseases such as Parkinson's and other neurodegenerative diseases, as well as stimulate vaccine strategies in which stimulation of autophagy may be of interest. Finally, the clinical use of rapamycin and other autophagy-modifying therapies may be altered by the common human variability in CD244, which could have implications for therapeutic success or dosing.
EXPERIMENTAL PROCEDURES
Further details on experimental procedures (i.e., handling of cells, antibodies, plasmids, transfections, lentiviral transductions, RNAi, qRT-PCR, and gene expression analysis) are provided in the Supplemental Experimental Procedures.
Cells and Reagents
Hapmap LCLs were purchased from the Coriell Institute. The LCL subjects assayed were as follows: 169 CEU; 197 YRI; 80 combined CHB (Han Chinese in Beijing, China) and JPT; 23 LWK; 22 TSI; seven African Americans in southwest USA; 15 combined Pima, Karitiana, Surui; and nine combined Mayan and Quechuan. Cells were maintained in RPMI 1640 media, supplemented with 10% fetal bovine serum (FBS), 2 mM glutamine, 100 U/ml penicillin-G, and 100 mg/ml streptomycin, and they were assayed in phenol red-free RPMI 1640 media with 10% FBS, unless stated otherwise.
Measurement of Autophagy by Flow Cytometry
Organelle acidification in live cells was measured using both LysoTracker Red DND-99 (Life Technologies) and CytoID (Enzo Life Sciences) initially, and the similar induction of a new population of cells in response to rapamycin or serum starvation was observed using both probes. LysoTracker Red DND-99 therefore was used for all subsequent measurements. The autophagic state of these distinct populations was determined by cell-sorting experiments described in the Supplemental Experimental Procedures.
Autophagy Screen
One day prior to assay, LCLs were counted on Guava Easycyte Plus flow cytometer and split to 1 3 10 5 /100 ml in assay media (RPMI 1640 without phenol red, 10% FBS). In the screen, each LCL was treated with 50 mM rapamycin or control buffer containing DMSO for 16 hr, stained with LysoTracker red DND-99, and fluorescence was measured on a Guava Easycyte Plus flow cytometer using Guava ExpressPro. Then 7,000 events were read per LCL per condition, and the subset of fluorescent cells gated in the M1 population upon rapamycin treatment thus were denoted in the figures as the percentage of cells with rapamycin-induced organelle acidification. For the screen, each LCL was assayed on three sequential passages separated by 3 days.
Computational Analysis
Descriptive statistics, linear regressions, and analyses were performed with GraphPad Prism 5. LD at the CD244 locus was examined with HaploView [17] . GWAS was conducted with PLINK [9] . Analysis was carried out with QFAM-parents and QFAM-total with 10 5 -10 9 adaptive permutations. QFAM procedures in PLINK use linear regression to test for association while employing permutation of within-and between-family components separately to control for family structure. Although protection from stratification is not as complete as with a strictly within-family test, consideration of parental phenotypes in QFAM results in a significant increase in power. Because of our small sample size for a GWAS, very low p values would only be obtained if the SNP had a very large genotypic effect. No SNPs reached genome-wide significance after correcting for multiple hypothesis testing; however, p values were not used to strictly define statistically significant associations but as a tool for narrowing down candidate SNPs for subsequent experimental analysis.
Statistical Analysis
For the entire screen, the intra-assay coefficient of variation (CV) was small (0.18 
Identification of Causal SNP
To find the putative causative genetic variants for CD244 expression, we performed eQTL analysis in CD244 and its flanking 15-kb region covering gene promoter and most proximal regulatory elements. The considered region also well captured the genetic variants, which were highly linked with rs512525. Sequencing data were collected from the 1000 Genomes Project [20] . The eQTL analysis was performed in 292 unrelated individuals in our sample set, including 16 CHB, 43 JPT, 75 GIH, 68 LWK, and 90 YRI. Linear regression was used to examine the association between SNPs and CD244 expression level at the additive model by PLINK [9] . The p value was calculated based on 10,000 permutations. The number of independent SNPs, used to do the Bonferroni correction, was determined by PLINK LD pruning. Briefly, in a sliding window with the size of 50 SNPs and the step of five SNPs, we removed one of a pair of linked SNPs if the LD r 2 was greater than 0.5. We regarded the remaining SNPs as independent. Next we extended the eQTL analysis to 331, all possible samples in our study. We used the 292 unrelated individuals as reference samples, and we imputed sequencing data for another 39 individuals by MaCH [44] . The imputation process was performed in each population, and then mach2qtl [45] was used to test the correlation of CD244 expression level and the imputed sequencing data. In addition, we explored the RNA-sequencing work of the Geuvadis project [21] to support our eQTL analysis (see the Supplemental Experimental Procedures). The pairwise LD was calculated by PLINK [9] . 
SUPPLEMENTAL INFORMATION
